Elsevier

Neuroscience Letters

Volume 336, Issue 3, 23 January 2003, Pages 185-187
Neuroscience Letters

Anti-prion antibodies for prophylaxis following prion exposure in mice

https://doi.org/10.1016/S0304-3940(02)01192-8Get rights and content

Abstract

Prion disease is characterized by a conformational change of the normal form of the prion protein (PrPC) to the scrapie-associated form (PrPSc). Since the emergence of new variant Creutzfeldt-Jakob disease a potentially large human population is at risk for developing prion disease. Currently, no effective treatment or form of post-exposure prophylaxis is available for prion disease. We recently showed that active immunization with recombinant PrP prolongs the incubation period of scrapie. Here we show that anti-PrP antibodies following prion exposure are effective at increasing the incubation period of the infection. Stimulation of the immune system is an important therapeutic target for the prion diseases, as well as for other neurodegenerative illnesses characterized by abnormal protein conformation.

Section snippets

Acknowledgements

This work was supported by the Alzheimer’s Association and NIH grants: AG17617, AG20245 and AG20197 and AR02594.

References (13)

There are more references available in the full text version of this article.

Cited by (100)

  • Recombinant prion protein vaccination of transgenic elk PrP mice and reindeer overcomes self-tolerance and protects mice against chronic wasting disease

    2018, Journal of Biological Chemistry
    Citation Excerpt :

    There are no preventive or therapeutic measures available against CWD, nor for other prion diseases such as Creutzfeldt-Jakob disease in humans, scrapie in sheep, and bovine spongiform encephalopathy in cattle. The concept of active and passive immunization has already been introduced for prion disease, and reduced prion propagation in vitro and in vivo, and it prolonged the incubation period in murine-adapted scrapie prion models after immunization (21–26). Vaccination in prion disease would be useful to prevent peripheral infection before prions reach the brain, as the vast majority of antibodies cannot cross the blood–brain barrier (25–27).

  • Vaccination strategies

    2018, Handbook of Clinical Neurology
  • Ethics in prion disease

    2013, Progress in Neurobiology
  • Exosome release from infected dendritic cells: A clue for a fast spread of prions in the periphery?

    2013, Journal of Infection
    Citation Excerpt :

    In fact, passive immunization of mice with anti-PrP antibodies recently confirmed that the prion load in lymphatic tissue was greatly reduced and scrapie incubation times significantly prolonged.172–175

View all citing articles on Scopus
View full text